Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns  Kuo-Hsuan Hsu, MD, Kun-Chieh Chen, MD,

Published bySukarno Hardja Modified over 5 years ago

Similar presentations

Presentation on theme: "Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns  Kuo-Hsuan Hsu, MD, Kun-Chieh Chen, MD,"— Presentation transcript:

1 Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns  Kuo-Hsuan Hsu, MD, Kun-Chieh Chen, MD, Tsung-Ying Yang, MD, Yi-Chen Yeh, MD, Teh-Ying Chou, MD, Hsuan-Yu Chen, PhD, Chi- Ren Tsai, PhD, Chih-Yi Chen, MD, Chung-Ping Hsu, MD, Jiun-Yi Hsia, MD, Cheng-Yen Chuang, MD, Ying-Huang Tsai, MD, Kuan-Yu Chen, MD, Ming-Shyan Huang, MD, Wu-Chou Su, MD, Yuh-Min Chen, MD, Chao A. Hsiung, PhD, Gee-Chen Chang, MD, Chien-Jen Chen, MD, Pan-Chyr Yang, MD  Journal of Thoracic Oncology  Volume 6, Issue 6, Pages (June 2011) DOI: /JTO.0b013e b0 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 A, Ground-glass opacity (GGO) ratio and epidermal growth factor receptor (EGFR) mutation status. B, Relationship of the GGO ratio, tumor size, and EGFR mutation status. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e b0) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Computed tomography (CT) image and histopathology of the tumor. A, CT scan with a part-solid pattern lung adenocarcinoma over right lung and (B) the low-power histopathology of the tumor in hematoxylin and eosin (H&E) stain (×20). There are invasive carcinoma cells in the central part of tumor (C) and in situ carcinoma cells arranged in a bronchioloalveolar pattern in the periphery (D). Both the central and peripheral tumor parts have the same EGFR mutation status, L858R. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e b0) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns  Kuo-Hsuan Hsu, MD, Kun-Chieh Chen, MD,"

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma  Chun-Ta Liao,

Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma  Chun-Ta Liao,
Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,

Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,
Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer:

Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer:
Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations 

Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations 
Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan  Chih-Yu Chen, Chia-Hung Chen, Te-Chun Shen, Wen-Chien.

Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan  Chih-Yu Chen, Chia-Hung Chen, Te-Chun Shen, Wen-Chien.
Quiz Page April 2011 American Journal of Kidney Diseases

Quiz Page April 2011 American Journal of Kidney Diseases
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease  Chung-Ping Hsu, MD,

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease  Chung-Ping Hsu, MD,
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.
Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment  Min-Shu Hsieh, MD, Jie-Yang Jhuang, MD, Syue-Fong Hua,

Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment  Min-Shu Hsieh, MD, Jie-Yang Jhuang, MD, Syue-Fong Hua,
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report  Tsu-Hui Shiao, MD, Yih-Leong Chang, MD, Chong-Jen Yu, MD, PhD, Yeun-Chung.

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report  Tsu-Hui Shiao, MD, Yih-Leong Chang, MD, Chong-Jen Yu, MD, PhD, Yeun-Chung.
Bob T. Li, M. B. B. S. , MPH, Dara S. Ross, MD, Dara L

Bob T. Li, M. B. B. S. , MPH, Dara S. Ross, MD, Dara L
Co-Overexpression of Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Adversely Affects the Postoperative Survival in Non-small Cell Lung Cancer 

Co-Overexpression of Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Adversely Affects the Postoperative Survival in Non-small Cell Lung Cancer 

Similar presentations

Ads by Google